[ad_1]
Reading time: 1 min
"Al-Ahsa today" – Al-Ahsa
MIT engineers have designed new combinations that can deliver drugs directly to cartilage, which can penetrate the depth of the cartilage and deliver drugs that can heal damaged tissue.
"Osteoporosis" is a disease that causes severe joint pain that affects more than 20 million people in the United States alone. Some treatments can relieve pain, but no treatment can reverse or slow down the damage. Cartilage associated with the disease.
"This is the best way to get directly into the damaged cells and introduce different types of treatments that alter the patient's motor behavior," said Dr. Paola Hammond, head of the Institute's Chemical Engineering Department, member of the Koch Institute of Integration.
In a study on rats, a number of researchers showed that the administration of an experimental drug called insulin-like growth factor (IGF-1) with this new substance avoids the damage Cartilaginous significantly and more effectively than the injection of the drug into the same joint.
A number of previous studies have shown that insulin-like growth factor (IGF-1) can help renew cartilage in animals, but many arthritis medications that have gave promising results in animal studies did not give good results Clinical Trials
Source link
